Ruben Prins

4PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Sep 14, 2026
The mRNA-Based Therapeutic Vaccine NTX250 Induces Potent Antitumor Immunity in HPV-Driven Cancers.

|Feb 27, 2026
Targeting STAT3 Promotes Tumor Cell Death and Enhances T-Cell Activity in HPV16-Positive Cancer.

Ruben Prins, Daniel J Fernandez, Diane M Da Silva

|Aug 19, 2025
HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophages.

Ruben Prins, Daniel J Fernandez, Omid Akbari

|Apr 26, 2025
Human Papillomavirus Type 16 Stimulates WAVE1- and WAVE2-Dependent Actin Protrusions for Endocytic Entry.

Daniel J Fernandez, Stephanie Cheng, Ruben Prins

Pageof 1

Frequent Collaborators

4 joint publications

W Martin Kast

2 joint publications

Diane M Da Silva

1 joint publications

Sarah F Hamm-Alvarez

1 joint publications

Omid Akbari

1 joint publications

James Turkson

1 joint publications

Meredith Leong

1 joint publications

Weiqun Liu

1 joint publications

Nicole Fay

1 joint publications

Ou Li

1 joint publications

Chris S Rae

Frequent Collaborators

4 joint publications

W Martin Kast

2 joint publications

Diane M Da Silva

1 joint publications

Sarah F Hamm-Alvarez

1 joint publications

Omid Akbari

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us